Comparing two markers to measure kidney function in intensive care
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial compares two different substances, mannitol and iohexol, to see which one better measures how well your kidneys are filtering waste. It is for patients in intensive care with sudden or ongoing kidney problems, as well as stable chronic kidney disease patients seen in outpatient clinics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have kidney failure that started suddenly (acute) or you have chronic kidney disease that is getting worse, and you are in the intensive care unit.
- Your blood circulation is stable, meaning your heart and blood pressure are steady.
- If you have chronic kidney disease and are not in the ICU, you are seen in an outpatient clinic.
- You do not have severe fluid buildup in your belly or legs (called ascites or edema).
- You have not received intravenous paracetamol (a painkiller) during the study period.
- You have not had an iohexol test in the past few days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps doctors better assess how well kidneys recover after acute kidney injury (a sudden loss of kidney function during hospitalization). You may be asked to participate in interviews, workshops, or have some medical measurements taken to help improve patient care.
This study tests if a simple blood test (cystatin) can detect kidney damage earlier in people with chronic kidney disease who receive contrast dye for imaging. It could help doctors act faster to protect kidneys.
This study tests whether two substances in urine (TIMP2 and IGFBP7) can help doctors predict which patients with sepsis-related kidney problems will get worse. If these markers work, doctors could identify high-risk patients earlier and treat them more aggressively.
This study looks at how kidney ultrasound can help monitor critically ill patients who need continuous dialysis for acute kidney injury. The results may help doctors better manage treatment.
This trial tests whether using a much smaller amount of contrast dye for an invasive heart scan is safer for people with acute kidney injury (AKI). It may help reduce further kidney stress while still allowing doctors to look at coronary (heart) arteries.
This study tests a new light-based method to check kidney function right after heart surgery or imaging tests that use contrast dye. It aims to catch kidney damage early, so doctors can treat it sooner.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.